ABSTRACT OBJECTIVE: To evaluate quality of life, sarcopenia and proteinuria, six and 12 months after infection with mild and moderate COVID-19. METHODS: We evaluated 253 individuals with mild (n = 119) and moderate (n = 134) clinical presentation for COVID-19 (reverse transcription-polymerase chain reaction—RT-PCR) after six (T6) and 12 (T12) months from the date of acute infection (T0). Quality of life, pain, risk for sarcopenia, muscle strength and proteinuria were assessed by the Short Form Health Survey 36 (SF-36) questionnaire; […]